Dublin, April 14, 2022 (GLOBE NEWSWIRE) -- The "Prebiotic Ingredients Market with Covid-19 Impact by Type (Oligosaccharides, Inulin, & Polydextrose), Application (Food & Beverage, Dietary Supplements, & Animal Feed), Source, Brand, Functionality, Bacterial Activity and Region - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
The global market for prebiotic ingredients is estimated at USD 6.3 Billion in 2022; it is projected to grow at a CAGR of 11.7% to reach USD 10.9 Billion by 2027. Awareness about prebiotics has gained popularity in recent years, stimulating scientific as well as industrial interest.
Wide uses of prebiotics as nutraceutical ingredients and increased awareness; these two points has acted as major drivers for the growth of this market. While the high R&D cost and stringent regulations by the government have acted as a challenge and restrain to the market. In recent years, the trend for prebiotics has been incorporating these ingredients in food and beverage items. Thus, making the food and beverage segment the largest one in 2022.
The Food & Beverages segment, by application, is projected to observe the fastest growth in the prebiotic ingredients market throughout the forecasted period
Prebiotic ingredients can be easily incorporated into daily diets through dairy, bakery, meat, cereal, and confectionery foods; they do not change the texture or taste of these products when used as an additional ingredient. The regular consumption of prebiotics increases immunity & reduces risks of certain diseases and conditions such as diarrhea, osteoporosis, obesity, cardiovascular diseases, and colon cancer.
The inulin segment by type is estimated to account for the largest market share in the prebiotic ingredients market
Inulin & fructooligosaccharides (FOS) are used in low-fat dairy and bakery & confectionery products such as yogurt, low-sugar ice cream, low-fat dairy desserts, fresh cheeses, milk beverages, creams, and dips to improve texture and taste. Inulin is used as a fat replacer, while FOS is used as a sugar replacer with an extra stabilizing effect on mousse emulsions. Inulin is considered an excellent product with the added advantage of its organoleptic properties, providing considerable benefits through its fibrous characteristics.
The roots, by source segment is projected to attain the fastest market growth in prebiotic ingredients over the forecast period.
Roots such as raw chicory root (cichorium intybus), jicama root (pachyrhizus erosus), Jerusalem artichoke root (helianthus tuberosus), black salsify root (scorzonera hispanica), Andean yacon root (smallanthus sonchifolius), and burdock root (arctium lappa) have prebiotic content. Raw chicory root contains maximum prebiotic fiber, that is, inulin, among all other roots. Chicory roots have also been linked to curing pulmonary diseases or tuberculosis, cancer, cough, and wounds. It is sometimes also used as a coffee substitute.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Lateral Flow Assay Components Market Overview
4.2 Regional Mix: Lateral Flow Assay Components Market
4.3 Asia-Pacific: Lateral Flow Assay Components Market, by Type and Country
4.4 Lateral Flow Assay Components Market: Geographical Growth Opportunities
4.5 Lateral Flow Assay Components Market: Developed Vs. Developing Countries
5 Market Overview
5.1 Introduction
5.2 Market Dynamics: Impact Analysis
5.2.1 Drivers
5.2.1.1 Growing Demand for Lateral Flow Assay Kits Due to the COVID-19 Pandemic
5.2.1.2 Growing Usage of Home-Based Lateral Flow Assay Devices
5.2.1.3 Growing Demand for Point-Of-Care Testing
5.2.1.4 Increasing Public-Private Investments to Develop Lateral Flow Assays
5.2.2 Restraints
5.2.2.1 Availability of Alternative Diagnostic Technologies
5.2.3 Opportunities
5.2.3.1 Evolving Applications of Lateral Flow Assays
5.2.4 Challenges
5.2.4.1 Requirement of Specialized Storage and Shipping Facilities for Membranes
5.3 Assessment of the Impact of COVID-19 on the Economic Scenario in the Lateral Flow Assay Components Market
5.4 Trends/Disruptions Impacting Customers' Businesses (Yc-Ycc) in the Lateral Flow Assay Components Market
5.5 Average Selling Price Trend
5.6 Ecosystem Market Map
5.7 Patent Analysis
5.7.1 Patent Publication Trends for Lateral Flow Assays
5.7.2 Jurisdiction Analysis: Top Applicants (Countries) for Patents in the Lateral Flow Assay Components Market
5.8 Value Chain Analysis
5.9 Regulatory Landscape
5.9.1 North America
5.9.2 Europe
5.9.3 Asia-Pacific
5.9.3.1 India
5.9.3.2 China
5.9.3.3 Japan
5.10 Technology Analysis
5.11 Key Conferences & Events During 2021-2023
5.12 Key Stakeholders & Buying Criteria
5.13 Porter's Five Forces Analysis
6 Lateral Flow Assay Components Market, by Type
6.1 Introduction
6.2 Membranes
6.2.1 Nitrocellulose Membranes
6.2.1.1 Advantages of Nitrocellulose Membranes Such as High Protein-Binding Affinity and Compatibility with a Wide Range of Detection Methods to Drive Market Growth
6.2.2 Other Membranes
6.3 Pads
6.3.1 Sample Pads
6.3.1.1 Ability to Promote Even and Controlled Distribution of Samples to Drive Market Growth
6.3.2 Conjugate Pads
6.3.2.1 Conjugate Pads Play An Important Role in Controlling the Performance of Lateral Flow Immunoassays
6.3.3 Absorbent Pads
6.3.3.1 Absorbent Pads Prevent Backflow - A Key Factor Driving Market Growth
6.4 Other Components
7 Lateral Flow Assay Components Market, by Application
7.1 Introduction
7.2 Clinical Testing
7.2.1 Infectious Disease Testing
7.2.1.1 Rising Demand for Infectious Disease Testing in Emerging Markets to Drive Market Growth
7.2.2 Pregnancy & Fertility Testing
7.2.2.1 Growing Infertility Levels Due to Changing Lifestyles - A Key Factor Driving Market Growth
7.2.3 Cardiac Marker Testing
7.2.3.1 Rising Prevalence of Cardiovascular Diseases and Growing Government Support to Drive Growth in this Market Segment
7.2.4 Cholesterol Testing/Lipid Profiling
7.2.4.1 Growing Prevalence of Obesity and Cvd - a Key Factor Driving Market Growth
7.2.5 Drugs-Of-Abuse Testing
7.2.5.1 Technological Advancements and a Growing Focus on Workplace Drug Testing Are Driving Market Growth
7.2.6 Other Clinical Testing Applications
7.3 Veterinary Diagnostics
7.3.1 Infectious Disease Outbreaks (Particularly in Large Livestock Animals) to Drive Market Growth
7.4 Food Safety & Environmental Testing
7.4.1 High Sensitivity and Ease of Use Are Key Factors Driving the Demand for Lateral Flow Assays for Food Safety Testing
7.5 Drug Development & Quality Testing
7.5.1 Increasing Focus on Product Safety and Quality Assurance to Drive Market Growth in the Coming Years
8 Lateral Flow Assay Components Market, by Technique
8.1 Introduction
8.2 Sandwich Assays
8.2.1 Sandwich Assays Provide Higher Levels of Assay Sensitivity and Specificity Than Other Assay Techniques - A Key Factor Driving Growth in this Market Segment
8.3 Competitive Assays
8.3.1 Reduced Selectivity and Sensitivity of Competitive Assays in Relation to Sandwich Assays Could Hamper Market Growth
8.4 Multiplex Detection Assays
8.4.1 Increasing Adoption of Multi-Analyte Assays Among Clinicians to Drive Market Growth
9 Lateral Flow Assay Components Market, by End-user
9.1 Introduction
9.2 Medical Device Manufacturing Companies
9.2.1 Increasing Use of Poc Tests is Driving the Adoption of Lateral Flow Assay Components Among Medical Device Manufacturing Companies
9.3 Medical Device Contract Manufacturing Companies
9.3.1 Growing Inclination Toward Fast and Early Diagnosis, Especially in Relation to the Current COVID-19 Scenario, Will Drive Market Growth
10 Lateral Flow Assay Components Market, by Region
11 Competitive Landscape
11.1 Overview
11.2 Key Player Strategies/Right to Win
11.3 Revenue Share Analysis for Key Players in the Lateral Flow Assay Components Market
11.4 Market Share Analysis
11.5 R&D Assessment of Key Players
11.6 Geographic Revenue Assessment of Key Players
11.7 Company Evaluation Quadrant
11.7.1 Stars
11.7.2 Pervasive Players
11.7.3 Emerging Leaders
11.7.4 Participants
11.8 Competitive Benchmarking
11.8.1 Overall Company Footprint
11.9 Competitive Scenario
11.9.1 Deals
11.9.2 Other Developments
12 Company Profiles
12.1 Key Players
12.1.1 Danaher Corporation (Pall Corporation and Cytiva Life Science)
12.1.2 Sartorius Stedim Biotech
12.1.3 Merck Kgaa
12.1.4 Ahlstrom-Munksjo
12.1.5 Advanced Microdevices Pvt. Ltd.
12.1.6 Dcn Diagnostics
12.2 Other Players
12.2.1 Fortis Life Sciences
12.2.2 Hangzhou Cobetter Filtration Equipment Co. Ltd
12.2.3 Axiva Sichem Biotech
12.2.4 Nupore Filtration System
12.2.5 Ballya Bio
12.2.6 Runbio Biotech Co. Ltd.
12.2.7 Neenah Gessner
12.2.8 Maxim Biomedical
12.2.9 Cytodiagnostics
12.2.10 Senova Gmbh
13 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/at0l3i
Attachment
